Radical Hysterectomy: Evolution Of Surgical Approach and Related Outcomes
RESurg
1 other identifier
observational
188
0 countries
N/A
Brief Summary
Prospective controlled study (Canadian Task Force II-2) : Comparison analysis regarding surgical outcomes, complications, overall survival (OS), disease free survival (DFS) and cancer specific survival between patients subjected to radical Hysterectomy either by open radical hysterectomy (ORH) or minimally invasive surgery (MIS): laparoscopic (LRH) or robotically assisted radical hysterectomy (RRH).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 1999
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 1999
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 15, 2018
CompletedFirst Posted
Study publicly available on registry
July 5, 2018
CompletedJuly 5, 2018
June 1, 2018
17.1 years
May 15, 2018
June 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall survival.
From date of randomization until the date of death from any cause.
up to 240 months
Secondary Outcomes (3)
Disease free survival
up to 240 months
Cancer specific survival
up to 240 month
surgical complication Rate
up to 28 days
Study Arms (3)
Early stage Cervical Cancer- Open Radical Hysterectomy(RH)
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a open RH at our institution as primary treatment were included in the study
Early stage Cervical Cancer- Laparoscopic Radical Hysterectomy
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a laparoscopic RH at our institution as primary treatment were included in the study
Early stage Cervical Cancer- Robotic radical Hysterectomy(RRH)
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a robotically assisted RH at our institution as primary treatment were included in the study
Interventions
Eligibility Criteria
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a RH at our institution
You may qualify if:
- Patients diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer.
- Subjected to Radical Hysterectomy.
You may not qualify if:
- Pregnant women in which a RH was performed at the time of caesarean section.
- Previous chemotherapy treatment
- Previous pelvic radiotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio Gil-Moreno, MD, PhD
Hospital Vall D'Hberon
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2018
First Posted
July 5, 2018
Study Start
May 1, 1999
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
July 5, 2018
Record last verified: 2018-06